Combined Behavioral and Drug Treatment of Overactive Bladder in Men

Trial Profile

Combined Behavioral and Drug Treatment of Overactive Bladder in Men

Completed
Phase of Trial: Phase II/III

Latest Information Update: 31 May 2017

At a glance

  • Drugs Tamsulosin (Primary) ; Tolterodine (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Acronyms COBALT
  • Most Recent Events

    • 27 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Apr 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
    • 03 Apr 2013 Planned End Date changed from 1 Jul 2012 to 1 Jul 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top